Cargando…
Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties
A model-based framework is presented to predict monoclonal antibody (mAb) pharmacokinetics (PK) in humans based on in vitro measures of antibody physiochemical properties. A physiologically based pharmacokinetic (PBPK) model is used to explore the predictive potential of 14 in vitro assays designed...
Autores principales: | Hu, Shihao, Datta-Mannan, Amita, D’Argenio, David Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067474/ https://www.ncbi.nlm.nih.gov/pubmed/35491902 http://dx.doi.org/10.1080/19420862.2022.2056944 |
Ejemplares similares
-
Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies
por: Datta-Mannan, Amita, et al.
Publicado: (2020) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of Monoclonal Antibody Pharmacokinetics From In Vitro Data
por: Jones, Hannah M., et al.
Publicado: (2019) -
Utility of physiologically based pharmacokinetic modeling to predict inter-antibody variability in monoclonal antibody pharmacokinetics in mice
por: Liu, Shufang, et al.
Publicado: (2023) -
Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules
por: Datta-Mannan, Amita, et al.
Publicado: (2021) -
A Physiologically‐Based Pharmacokinetic Model for the Prediction of “Half‐Life Extension” and “Catch and Release” Monoclonal Antibody Pharmacokinetics
por: Jones, Hannah M., et al.
Publicado: (2020)